Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity

Journal of General Virology

Volumn 88, Issue 1, 2007, Pages 242-250

  Cerboni, Cristina ^a   Neri, Francesca ^b   Casartelli, Nicoletta ^b,e   Zingoni, Alessandra ^a   Cosman, David ^c   Rossi, Paolo ^b,d   Santoni, Angela ^a   Doria, Margherita ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c AMGEN INC   (United States)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; LIGAND; NATURAL KILLER CELL RECEPTOR NKG2D; NEF PROTEIN;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS MUTATION; WILD TYPE;

CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GENE PRODUCTS, NEF; HIV-1; HUMANS; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IMMUNOLOGIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846141778     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82125-0     Document Type: Article

References (39)

1. Arold, S. T. & Baur, A. S. (2001). Dynamic Nef and Nef dynamics: how structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 26, 356-363.
2. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. & Spies, T. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729.
3. Baur, A. (2004). Functions of the HIV-1 Nef protein. Curr Drug Targets Immune Endocr Metabol Disord 4, 309-313.
4. Bonaparte, M. I. & Barker, E. (2003). Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 17, 487-494.
5. Carl, S., Greenough, T. C., Krumbiegel, M., Greenberg, M., Skowronski, J., Sullivan, J. L. & Kirchhoff, F. (2001). Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 75, 3657-3665.
6. Casartelli, N., Di Matteo, G., Argentini, C. & 7 other authors (2003a). Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. AIDS 17, 1291-1301.
7. Casartelli, N., Di Matteo, G., Potesta, M., Rossi, P. & Doria, M. (2003b). CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression. J Virol 77, 11536-11545.
8. Cerboni, C., Mousavi-Jazi, M., Wakiguchi, H., Carbone, E., Kärre, K. & Söderström, K. (2001). Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur J Immunol 31, 2926-2935.
9. Chalupny, N. J., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A. & Cosman, D. (2003). ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305, 129-135.
10. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J., Richman, D. D. & Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol 68, 2906-2914.
11. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. & Baltimore, D. (1999). The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671.
12. Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
13. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. & Chalupny, N. J. (2001). ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133.
14. Deacon, N. J., Tsykin, A., Solomon, A. & 17 other authors (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
15. Doms, R. W. & Trono, D. (2000). The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 14, 2677-2688.
16. Eger, K. A. & Unutmaz, D. (2004). Perturbation of natural killer cell function and receptors during HIV infection. Trends Microbiol 12, 301-303.
17. Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190.
18. Gervaix, A., West, D., Leoni, L. M., Richman, D. D., Wong-Staal, F. & Corbeil, J. (1997). A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc Natl Acad Sci U S A 94, 4653-4658.
19. Geyer, M., Fackler, O. T. & Peterlin, B. M. (2001). Structure-function relationships in HIV-1 Nef. EMBO Rep 2, 580-585.
20. Groh, V., Wu, J., Yee, C. & Spies, T. (2002). Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734-738.
21. Grzesiek, S., Stahl, S. J., Wingfield, P. T. & Bax, A. (1996). The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 35, 10256-10261.
22. Hanna, Z., Kay, D. G., Rebai, N., Guimond, A., Jothy, S. & Jolicoeur, P. (1998). Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
23. Kirchhoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332, 228-232.
24. Lanier, L. L. (2005). NK cell recognition. Annu Rev Immunol 23, 225-274.
25. Le Gall, S., Erdtmann, L., Benichou, S., Berlioz-Torrent, C., Liu, L., Benarous, R., Heard, J. M. & Schwartz, 0. (1998). Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495.
26. Liu, X., Schrager, J. A., Lange, G. D. & Marsh, J. W. (2001). HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular Nef concentrations. J Biol Chem 276, 32763-32770.
27. Lodoen, M. B. & Lanier, L. L. (2005). Viral modulation of NK cell immunity. Nat Rev Microbiol 3, 59-69.
28. Maier, R., Bartolomè-Rodrìguez, M. M., Moulon, C., Weltzien, H. U. & Meyerhans, A. (2000). Kinetics of CXCR4 and CCR5 up-regulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4(+) T lymphocytes. Blood 96, 1853-1856.
29. McMichael, A. (1998). T cell responses and viral escape. Cell 93, 673-676.
30. Pende, D., Cantoni, C., Rivera, P. & 8 other authors (2001). Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 31, 1076-1086.
31. Peterlin, B. M. & Trono, D. (2003). Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 3, 97-107.
32. Pross, H. F., Callerwaert, D. & Rubin, P. (1986). Assay for NK cell cytotoxicity - their values and pitfalls. In Immunobiology of Natural Killer Cells, pp. 2-20. Edited by E. Lotzova & R. B. Herberman. Boca Raton, FL: CRC Press.
33. Raulet, D. H. (2003). Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3, 781-790.
34. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M., Tantravahi, R. & Ritz, J. (1996). Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 24, 406-415.
35. Rölle, A., Mousavi-Jazi, M., Eriksson, M., Odeberg, J., Söderberg-Nauclér, C., Cosman, D., Karre, K. & Cerboni, C. (2003). Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 171, 902-908.
36. Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H. G. & Steinle, A. (2003). Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102, 1389-1396.
37. Schrager, J. A. & Marsh, J. W. (1999). HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A 96, 8167-8172.
38. Schwartz, O., Riviere, Y., Heard, J. M. & Danos, O. (1993). Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J Virol 67, 3274-3280.
39. Welte, S. A., Sinzger, C., Lutz, S. Z., Singh-Jasuja, H., Sampaio, K. L., Eknigk, U., Rammensee, H. G. & Steinle, A. (2003). Selective intracellular retention of vitally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33, 194-203.